Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Onex Reports First Quarter 2026 Results
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Max Power Signs MOU with City of Moose Jaw to Advance Natural Hydrogen Commercialization Within Saskatchewan’s Largest Industrial Corridor
-
Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress
-
OTC Markets Group Welcomes Bellavista Resources Ltd to OTCQX
-
Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses
-
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
-
Aurora Mobile’s AI-Native Solution Drives 24/7 Real Estate Conversions for Japan’s Axios Management
-
CECO Environmental and Thermon Group Holdings Announce Election Deadline for Thermon Stockholders to Elect Form of Merger Consideration
-
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
-
Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder
-
CCC Intelligent Solutions Holdings Inc. to Present at J.P. Morgan Global Technology, Media and Communications Conference
-
Purple Biotech Reports First Quarter 2026 Financial Results and Business Highlights
-
As Victoria Day Weekend Approaches, MADD Canada Urges to Report Impaired Driving Through Campaign 911
-
Nobel Provides Update on Pampa Austral Drilling and Cuprita Project, Chile
-
Bera hf.: Verkaskipting stjórnar í kjölfar aðalfundar
-
Genco Shipping & Trading Limited Board of Directors Unanimously Rejects Diana Shipping’s Unsolicited Tender Offer
-
New Era Energy & Digital Files Q1 2026 Form 10-Q and Highlights Strategic Progress
-
Form 8.3 - Picton Property Income Limited
-
Man Group PLC : Form 8.3 - A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Form 8.3 - LondonMetric Property Plc & Schroder REIT Ltd
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Form 8.3 - Advanced Medical Solutions Group
-
Man Group PLC : Form 8.3 - JTC Plc
-
Man Group PLC : Form 8.3 - Senior plc
-
Man Group PLC : Form 8.3 - DCC Plc
-
Genco Shipping & Trading Limited Board of Directors Unanimously Rejects Diana Shipping’s Unsolicited Tender Offer
-
New Era Energy & Digital Files Q1 2026 Form 10-Q and Highlights Strategic Progress
-
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
-
FTAI Aviation Announces Full Redemption of Outstanding 8.25% Fixed-Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares
-
Interfor Reports Voting Results from Annual General Meeting
-
Clearway Energy, Inc. Announces General Counsel Transition
-
Invitation to Nova’s Quarterly Update Webinar
-
Form 8.3 - TATE & LYLE PLC
-
Market Analysis: Dmitry Shubov Remarks on Bridging the $3B Gap Between U.S. Capital and S.E.A. Multilingual Legal AI
-
Director/PDMR Shareholding
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 14 05 2026] - (CGAML)
-
Inside information: The Financial Supervisory Authority has imposed a combined penalty payment of 400 000 euros on Oma Savings Bank Plc due to failures related to maintaining insider lists
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 14 05 2026] - (CGWL)
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Form 8.3 - [ANIMALCARE GROUP PLC - 14 05 2026] - (CGWL)
-
Form 8.5 (EPT/RI)- Advanced Medical Solutions Group plc
-
Form 8.5 (EPT/RI)-NCC Group plc
-
H World Group Limited Reports First Quarter of 2026 Unaudited Financial Results
-
Neo-Concept International Announces Share Consolidation
-
Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC
-
ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update

